Brief: Alzamend Neuro Says On Sept 8, Entered At-The-Market Issuance Sales Agreement To Sell Common Shares Of Up To About $9.8 Million

Alzamend Neuro

08/09/2023 22:10

Sept 8 (Reuters) - Alzamend Neuro Inc  ALZN.O :
    * ALZAMEND NEURO- ON SEPT 8, ENTERED AT-THE-MARKET ISSUANCE
SALES
AGREEMENT TO SELL COMMON SHARES OF UP TO ABOUT $9.8 MILLION


Further company coverage:  ALZN.O 

 ((Reuters.Briefs@thomsonreuters.com;))